Humanigen Inc (fka HGENQ)

[MWM]

BioJerry
Bullish
9m
$HGEN
at a $1b market cap this is about 3x to 5x under valued. Most of that value can be realized with a successful phase 3 trial for Lenz set to read out in the next few weeks. This simultaneously unlocks the value of Lenz as a combo treatment with CAR-T therapy for Cancer.

As I’ve posted before:
“The hyper-inflammatory response turning COVID-19 into a life-threatening disease shares conceptual and molecular resemblance with the cytokine storm developing during the macrophage activation syndrome, or with the cytokine release syndrome following chimeric antigen receptor T (CAR-T)-cell therapy”

In essence we can derisk the second much more VALUE creating trial with the results of the first!